Tfg Asset Management Gp LTD Autolus Therapeutics PLC Transaction History

Tfg Asset Management Gp LTD

$316 Million
Q4 2024

A detailed history of Tfg Asset Management Gp LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 8,250,000 shares of AUTL stock, worth $16.8 Million. This represents 6.14% of its overall portfolio holdings.

Number of Shares

8,250,000

Previous 8,000,000 3.13%

Holding current value

$16.8 Million

Previous $29 Million 33.24%

% of portfolio

6.14%

Previous 10.85%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.18 - $4.8 $545,000 - $1.2 Million	250,000 Added 3.13%	8,250,000 $19.4 Million
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $1.58 Million - $2.69 Million	474,318 Added 6.3%	8,000,000 $27.8 Million
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $2.56 Million - $3.46 Million	-474,318 Reduced 5.93%	7,525,682 $48 Million
Q4 2023 Feb 14, 2024	SELL	$2.13 - $6.63 $8.52 Million - $26.5 Million	-4,000,000 Reduced 33.33%	8,000,000 $51.5 Million
Q2 2023 Aug 14, 2023	BUY	$1.64 - $3.21 $3.28 Million - $6.42 Million	2,000,000 Added 20.0%	12,000,000 $28.6 Million
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $2.98 Million - $3.83 Million	1,700,000 Added 20.48%	10,000,000 $18.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $9.15 Million - $17.2 Million	5,260,619 Added 173.08%	8,300,000 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.76 $40,734 - $75,079	19,968 Added 0.66%	3,039,381 $6.5 Million
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.68 $394,691 - $905,467	193,476 Added 6.85%	3,019,413 $8.55 Million
Q1 2022 May 16, 2022	BUY	$3.52 - $5.46 $443,298 - $687,616	125,937 Added 4.66%	2,825,937 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$5.1 - $7.0 $1.02 Million - $1.4 Million	200,000 Added 8.0%	2,700,000 $14 Million
Q2 2021 Aug 16, 2021	BUY	$4.78 - $7.96 $307,287 - $511,716	64,286 Added 2.64%	2,500,000 $16.6 Million
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $1.57 Million - $2.67 Million	285,714 Added 13.29%	2,435,714 $14 Million
Q2 2020 Aug 14, 2020	BUY	$5.38 - $16.14 $900,606 - $2.7 Million	167,399 Added 8.44%	2,150,000 $34.5 Million
Q1 2020 May 15, 2020	BUY	$4.2 - $13.0 $2.87 Million - $8.87 Million	682,601 Added 52.51%	1,982,601 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$9.79 - $16.72 $2.94 Million - $5.02 Million	300,000 Added 30.0%	1,300,000 $16.1 Million
Q2 2019 Aug 14, 2019	BUY	$15.1 - $31.25 $2.24 Million - $4.64 Million	148,369 Added 17.42%	1,000,000 $16.1 Million
Q1 2019 May 15, 2019	BUY	$24.38 - $34.71 $1.26 Million - $1.79 Million	51,631 Added 6.45%	851,631 $26.8 Million
Q4 2018 Feb 14, 2019	BUY	$24.21 - $48.01 $238,468 - $472,898	9,850 Added 1.25%	800,000 $26.3 Million
Q3 2018 Nov 14, 2018	BUY	$20.86 - $33.33 $16 Million - $25.5 Million	765,150 Added 3060.6%	790,150 $24.2 Million
Q2 2018 Aug 14, 2018	BUY	$25.0 - $27.75 $625,000 - $693,750	25,000 New	25,000 $670,000

Others Institutions Holding AUTL

# of Institutions

111

Shares Held

156M

Call Options Held

Put Options Held

116K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $185M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Asset Management Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Asset Management Gp LTD with notifications on news.

Account

Tfg Asset Management Gp LTD Autolus Therapeutics PLC Transaction History